Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1533.119
- -1.897-0.12%
Close Dec 26 16:00 ET
1542.794High1529.321Low
1529.321Open1535.016Pre Close45.99MVolume4Rise56.49P/E (Static)2.97BTurnover--Flatline0.44%Turnover Ratio1.44TMarket Cap3Fall1.33TFloat Cap
Constituent Stocks: 7Top Rising: ALT+5.96%
Chart looks good with double bottom. Next resistance is 26.83. Once it breaks the resistance, next hit point will be 27.15. Strong buying volume is needed to push up the stock and ensure the up trend is sustainable.
The stock is trading above 60EMA but below the 120EMA. It has broken above the upper band and it has turned bullish. RSI is turning up. It is likely on the up trend.
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
it was fun..
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...
No comment yet